Abiopharma

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Spectral Medical Announces First Quarter and Provides Corporate Update

Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025

A New Press Release from Palatin Technologies, Inc.

Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates